Stocks-Prognosis.com
Search on StockPrognosis.com
To search on the site stockprognosis.com enter the name of the ticker, company name, or search phrase
Sections of the site



AstraZeneca PLC AZN: One of the Most Promising Cancer Stocks, Hedge Funds Say

November 30, 2024
AstraZeneca PLC (AZN) has emerged as one of the most promising stocks in the cancer sector, according to leading hedge funds. With its focus on innovative cancer treatments and breakthrough research, the company has garnered significant attention from investors. AstraZeneca's commitment to growth in the U.S. market further enhances its investment potential. Considering the positive outlook for the company, industry experts recommend consulting professionals at Stocks Prognosis for accurate stock movement forecasts.
If you want to leave a comment, then you need Login or Register





Other data for AZN

Related data

AZNSeptember 3, 2025ASTRAZENECA PLC Hits QuantWave Forecast, Generating 16.24% Profit  ~2 min.

ASTRAZENECA PLC has successfully reached the price target forecasted by QuantWave on July 11, 2025. The forecast indicated a long position with a price of 70.64 $....


AZNSeptember 3, 2025ASTRAZENECA PLC Hits 11.81% Profit Target as Forecasted by QuantWave  ~1 min.

ASTRAZENECA PLC's stock has successfully reached the price target forecasted by QuantWave, resulting in a profit of 11.81%. The forecast signal was given on 2025-08-01 when the stock was trading at 73....


AZNSeptember 3, 2025ASTRAZENECA PLC Stock Hits QuantWave Price Target with Profit of 19.38%  ~1 min.

On July 17, 2025, QuantWave, the automated forecasting platform, issued a long signal for ASTRAZENECA PLC stock when it was trading at 68.78 $....


AZNSeptember 3, 2025ASTRAZENECA PLC Stock Hits Price Target Forecast with 17.98% Profit  ~1 min.

On July 16, 2025, QuantWave's automated forecasting platform issued a signal for ASTRAZENECA PLC, predicting a long position with the stock trading at $69.6....


AZNSeptember 3, 2025ASTRAZENECA PLC Hits Price Target Forecast with 13.12% Profit  ~2 min.

On July 31, 2025, QuantWave, an automated forecasting platform, issued a long signal for ASTRAZENECA PLC when the stock was trading at $72.59....


AZNSeptember 3, 2025ASTRAZENECA PLC Hits QuantWave Forecast Target with 11.64% Profit  ~2 min.

ASTRAZENECA PLC has successfully reached the price target forecasted by QuantWave, resulting in a profit of 11.64%. The forecast signal was issued on August 8, 2025, with the stock priced at $73....


AZNSeptember 3, 2025ASTRAZENECA PLC Stock Hits Price Target with 12.34% Profit: QuantWave Forecast Success  ~1 min.

ASTRAZENECA PLC stock has successfully achieved the price target forecast set by QuantWave, resulting in a profit of 12.34%. The forecast signal was generated on August 6, 2025, with a price of $73....


AZNSeptember 3, 2025QuantWave Successfully Hits Price Target Forecast for AstraZeneca PLC, Yielding 15.25% Profit  ~2 min.

On July 14, 2025, QuantWave, the automated forecasting platform, issued a signal to go long on AstraZeneca PLC with a price of $71.24....


AZNAugust 25, 2025AstraZeneca's Breakthrough Study on Advanced Biliary Tract Cancer  ~1 min.

AstraZeneca PLC has recently announced groundbreaking results from their new study on advanced biliary tract cancer, showing promising potential for a new treatment option in cancer care....


AZNAugust 22, 2025ASTRAZENECA PLC Hits Price Target Forecast with 20.55% Profit  ~1 min.

On January 23, 2025, QuantWave issued a long signal for ASTRAZENECA PLC with a price of 67.17 $. The forecast proved to be accurate as the stock reached the target price of 80....


AZNJanuary 2, 2025AstraZeneca PLC Announces Breakthrough in Cancer Treatment Research  ~2 min.

AstraZeneca PLC, a leading global pharmaceutical company, has reported a significant breakthrough in its cancer treatment research....


AZNJanuary 1, 2025New breakthrough in medical research announced by AstraZeneca PLC AZN  ~2 min.

Leading pharmaceutical company AstraZeneca PLC AZN has made a groundbreaking discovery in the field of medical research....


AZNMarch 20, 2025AstraZeneca AZN: Among the Best Diabetes Stocks to Buy According to Billionaires  ~1 min.

AstraZeneca PLC (AZN) has been recognized as one of the best diabetes stocks to buy by billionaires....


AZNOctober 31, 2024AstraZeneca PLC Collaborates with Monopar Therapeutics on Rare Disease Treatment  ~1 min.

Monopar Therapeutics, a biopharmaceutical company specializing in rare disease treatments, has announced a groundbreaking partnership with AstraZeneca PLC....


AZNJanuary 2, 2025AstraZeneca PLC Develops Breakthrough Treatment for Rare Disease  ~2 min.

AstraZeneca PLC, a leading pharmaceutical company, has announced a major breakthrough in the development of a treatment for a rare disease....